VVA
KNTE
Vida Ventures Advisors’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,207,772
| Closed | -$5.23M | – | 7 |
|
|
2023
Q4 | $5.23M | Hold |
2,207,772
| – | – | 6.23% | 5 |
|
|
2023
Q3 | $3.09M | Hold |
2,207,772
| – | – | 4.78% | 6 |
|
|
2023
Q2 | $6.69M | Hold |
2,207,772
| – | – | 8.73% | 4 |
|
|
2023
Q1 | $13.8M | Hold |
2,207,772
| – | – | 18.88% | 3 |
|
|
2022
Q4 | $13.5M | Hold |
2,207,772
| – | – | 18.1% | 2 |
|
|
2022
Q3 | $26.4M | Sell |
2,207,772
-539,661
| -20% | -$6.45M | 23.68% | 2 |
|
|
2022
Q2 | $34.6M | Hold |
2,747,433
| – | – | 29.28% | 1 |
|
|
2022
Q1 | $30.9M | Hold |
2,747,433
| – | – | 17.99% | 2 |
|
|
2021
Q4 | $48.7M | Hold |
2,747,433
| – | – | 18.21% | 2 |
|
|
2021
Q3 | $63.2M | Hold |
2,747,433
| – | – | 18.11% | 2 |
|
|
2021
Q2 | $64M | Hold |
2,747,433
| – | – | 16.04% | 3 |
|
|
2021
Q1 | $85.6M | Buy |
2,747,433
+359
| +0% | +$11.2K | 21.63% | 2 |
|
|
2020
Q4 | $109M | Buy |
+2,747,074
| New | +$109M | 22.43% | 2 |
|